129 related articles for article (PubMed ID: 9161532)
1. [Hepatitis C: screening and treatment].
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S213-6. PubMed ID: 9161532
[No Abstract] [Full Text] [Related]
2. [Hepatitis C: screening and treatment].
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S202-11. PubMed ID: 9161531
[No Abstract] [Full Text] [Related]
3. [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].
Payen JL
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S175-89. PubMed ID: 9161529
[No Abstract] [Full Text] [Related]
4. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
Larrey D
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
[No Abstract] [Full Text] [Related]
5. [Screening and treatment of acute hepatitis C].
Grangé JD
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):285-7. PubMed ID: 12700513
[No Abstract] [Full Text] [Related]
6. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
Pascal JP
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
[No Abstract] [Full Text] [Related]
7. [Should hepatitis C be treated?].
Tran A
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S148-53. PubMed ID: 9161526
[No Abstract] [Full Text] [Related]
8. [Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?].
Pawlotsky JM
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S41-50. PubMed ID: 9161513
[No Abstract] [Full Text] [Related]
9. [Treatment of chronic hepatitis C. Many interrogatives and some answers].
Ampurdanès S; Rodés J
Rev Clin Esp; 1996 Oct; 196(10):667-9. PubMed ID: 9005467
[No Abstract] [Full Text] [Related]
10. [How to follow treated and untreated chronic hepatitis B and C].
Adler M; Golstein P; Botembe N; Bourgeois N
Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
[TBL] [Abstract][Full Text] [Related]
12. [Chronic hepatitis C: therapeutic uncertainties].
Blondon H; Bergmann JF
Gastroenterol Clin Biol; 1996; 20(12):1043-6. PubMed ID: 9033847
[No Abstract] [Full Text] [Related]
13. Dose-finding study of interferon alfa-n3 in hepatitis C.
Hoofnagle JH; Everhart J
Hepatology; 1997 Nov; 26(5):1366-7. PubMed ID: 9362387
[No Abstract] [Full Text] [Related]
14. Hepatitis C: be positively aware of the risk of transmission and treatment.
Johnson B
Posit Aware; 2002; 13(6):29-31. PubMed ID: 12484333
[No Abstract] [Full Text] [Related]
15. Treatment of chronic hepatitis C.
Nelson DR; Davis GL
Compr Ther; 1997 Apr; 23(4):269-76. PubMed ID: 9167919
[No Abstract] [Full Text] [Related]
16. Clinical use of interferons in hepatology.
Civeira MP
Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():33-4. PubMed ID: 8899691
[No Abstract] [Full Text] [Related]
17. A rational approach to hepatitis C.
Mills P; McPeake J; McCruden E
Practitioner; 1996 Mar; 240(1560):172-6. PubMed ID: 8710731
[No Abstract] [Full Text] [Related]
18. [Dysthyroidism and interferon-alpha: the withdrawal of interferon should not be systematic].
Chédin P; Cahen-Varsaux J; Demmane S
Gastroenterol Clin Biol; 1995 Apr; 19(4):442-4. PubMed ID: 7672530
[No Abstract] [Full Text] [Related]
19. Hepatitis C. Understanding the issues.
Miller SK
Adv Nurse Pract; 2000 Dec; 8(12):49-50, 87-8. PubMed ID: 12397910
[No Abstract] [Full Text] [Related]
20. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
Tambini R; Quattrini A; Fracassetti O; Nemni R
J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
